Skip to main content

Table 3

From: Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice

Groups

Challenge with APP1

Challenge with APP2

 

Survival

Lung lesion

Survival

Lung lesion

Control

0/10

Severeb

0/10

Severeb

Group I

9/10

Slighta

Severeb

9/10

Slighta

Severeb

Group II

5/10

Moderatea

Severeb

6/10

Moderatea

Severeb

Group III

6/10

Moderatea

Severeb

7/10

Moderatea

Severeb

  1. a Surviving mice; b Dead mice